Real-world effectiveness and safety of fixed-ratio combination insulin glargine 100 u/ml plus lixisenatide in adults with type 2 diabetes (T2DM): subanalysis of the international, multicentre, prospective observational study SUCCESS in the Russian population

AIM: To evaluate the impact a fixed-ratio combination of insulin glargine(100U/ml) and lixisenatide(iGlarLixi) on the glycemic control in Russian study T2D population uncontrolled on OAD ± insulin therapy in real-world settings.MATERIALS AND METHODS: The Russian subanalysis of international, multice...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. K. Vikulova, R. A. Atanesyan, S. D. Movsesyan, Yu. P. Kasatkina, A. A. Perevyazka, E. L. Zaytseva, M. I. Kharakhulakh, N. V. Andreeva, I. A. Krivosheyeva, S. V. Vorobyev, T. V. Saprina, D. A. Avaliani, M. A. Prudnikova, M. V. Shestakova, N. G. Mokrysheva
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2024-11-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus type 2 fixed ratio combination insulin glargine lixisenatide real world settings
Online Access:	https://www.dia-endojournals.ru/jour/article/view/13236
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Real-world effectiveness and safety of fixed-ratio combination insulin glargine 100 u/ml plus lixisenatide in adults with type 2 diabetes (T2DM): subanalysis of the international, multicentre, prospective observational study SUCCESS in the Russian population

Similar Items